Trial Outcomes & Findings for StepRite Evaluation (NCT NCT02270684)

NCT ID: NCT02270684

Last Updated: 2017-05-11

Results Overview

The KOOS is a validated tool to measure pain and quality of life in patients after TKA

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

Baseline, 4, 10, 24 weeks

Results posted on

2017-05-11

Participant Flow

Participant milestones

Participant milestones
Measure
Device
Participants in this arm will receive the StepRite device. They will have a remote visit with their Physical Therapist in place of one in-person visit per week during the outpatient phase of their treatment StepRite: The StepRite device uses an insole to monitor motion, and relays this information to the physical therapist via a smart phone app and web link. Set exercises can be programmed into the app for the participant to complete
Usual and Customary Care
Participants in this arm will undergo usual care and will not be issued with the StepRite device
Overall Study
STARTED
1
3
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
1
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Device
Participants in this arm will receive the StepRite device. They will have a remote visit with their Physical Therapist in place of one in-person visit per week during the outpatient phase of their treatment StepRite: The StepRite device uses an insole to monitor motion, and relays this information to the physical therapist via a smart phone app and web link. Set exercises can be programmed into the app for the participant to complete
Usual and Customary Care
Participants in this arm will undergo usual care and will not be issued with the StepRite device
Overall Study
Lost to Follow-up
0
3
Overall Study
Study terminated
1
0

Baseline Characteristics

StepRite Evaluation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Device
n=1 Participants
Participants in this arm will receive the StepRite device. They will have a remote visit with their Physical Therapist in place of one in-person visit per week during the outpatient phase of their treatment StepRite: The StepRite device uses an insole to monitor motion, and relays this information to the physical therapist via a smart phone app and web link. Set exercises can be programmed into the app for the participant to complete
Usual and Customary Care
n=3 Participants
Participants in this arm will undergo usual care and will not be issued with the StepRite device
Total
n=4 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
1 participants
n=5 Participants
3 participants
n=7 Participants
4 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 4, 10, 24 weeks

Population: Due to early termination, no evaluable data was collected

The KOOS is a validated tool to measure pain and quality of life in patients after TKA

Outcome measures

Outcome data not reported

Adverse Events

Device

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual and Customary Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Christopher Powers

University of Southern California

Phone: 3234422900

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place